United Kingdom

NAPP PHARMACEUTICALS LIMITED

Reference: GB-PPON-PJJB-3288-JNGG

Awards

€1,582,615,501

Total awarded

Recent awards

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £166,347,397
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 June 2026 · £665,389,588
NHS National Branded Interim - 1 June 2026
10 April 2026 · £529,090,780
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
NHS National Branded Interim - 1 June 2026
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.